KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Ingredients (ALTO) Gains from Sales and Divestitures (2016 - 2025)

Alto Ingredients (ALTO) has 11 years of Gains from Sales and Divestitures data on record, last reported at $1.6 million in Q4 2024.

  • For Q4 2024, Gains from Sales and Divestitures rose 191.96% year-over-year to $1.6 million; the TTM value through Dec 2024 reached $1.6 million, up 191.96%, while the annual FY2024 figure was $1.6 million, 191.96% up from the prior year.
  • Gains from Sales and Divestitures reached $1.6 million in Q4 2024 per ALTO's latest filing, up from $547000.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $1.6 million in Q4 2024 and bottomed at $547000.0 in Q4 2023.
  • Average Gains from Sales and Divestitures over 5 years is $1.2 million, with a median of $1.3 million recorded in 2020.
  • Peak YoY movement for Gains from Sales and Divestitures: crashed 47.95% in 2023, then soared 191.96% in 2024.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $1.3 million in 2020, then increased by 18.22% to $1.5 million in 2021, then crashed by 31.08% to $1.1 million in 2022, then plummeted by 47.95% to $547000.0 in 2023, then skyrocketed by 191.96% to $1.6 million in 2024.
  • Per Business Quant database, its latest 3 readings for Gains from Sales and Divestitures were $1.6 million in Q4 2024, $547000.0 in Q4 2023, and $1.1 million in Q4 2022.